Conjugation, that is, covalent linkage, to immunological proteins is a common strategy to address the low immunogenicity issue of carbohydrate antigens in vaccine development. This chapter describes an easy and efficient method for oligosaccharide-protein conjugation employing dicarboxylic acid linkers. In this regard, a free amino group is introduced to an oligosaccharide antigen to facilitate coupling with the bifunctional linker upon reaction with its corresponding disuccinimidyl ester. The resultant monosuccinimidyl ester of the oligosaccharide antigen then reacts with the free amino groups of a carrier protein to provide the desired oligosaccharide-protein conjugate.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-0716-0795-4_15DOI Listing

Publication Analysis

Top Keywords

oligosaccharide antigen
12
free amino
8
antigen conjugation
4
conjugation carrier
4
carrier proteins
4
proteins formulate
4
formulate glycoconjugate
4
glycoconjugate vaccines
4
vaccines conjugation
4
conjugation covalent
4

Similar Publications

Rotaviruses, non-enveloped viruses with a double-stranded RNA genome, are the leading etiological pathogen of acute gastroenteritis in young children and animals. The P[11] genotype of rotaviruses exhibits a tropism for neonates. In the present study, a binding assay using synthetic oligosaccharides demonstrated that the VP8* protein of P[11] porcine rotavirus (PRV) strain 4555 binds to lacto-N-neotetraose (LNnT) with the sequence Galβ1,4-GlcNAcβ1,3-Galβ1,4-Glc, one of the core parts of histo-blood group antigen (HBGA) and milk glycans.

View Article and Find Full Text PDF

Enhanced Antitumor Immunity of a Globo H-Based Vaccine Enabled by the Combination Adjuvants of 3D-MPL and QS-21.

Angew Chem Int Ed Engl

December 2024

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Carbohydrate-Based Drug Research Center, 555 Zu-Chong-Zhi Road, 201203, Shanghai, CHINA.

Globo H, a specific carbohydrate antigen overexpressed on various human malignancies, has attracted considerable interest as an antigenic target for anticancer vaccine development. Despite several Globo H-based carbohydrate vaccines that have been designed, efficient access to Globo H hexasaccharide antigen and development of powerful adjuvants for enhancing antitumor immunity remain challenging. Herein, we reported a streamlined chemoenzymatic approach to prepare this hexasaccharide antigen, relying on chemical synthesis of Gb5 pentasaccharide by a stereoconvergent [2+3] strategy and subsequent enzymatic α-fucosylation to easily install α1,2-fucose residue.

View Article and Find Full Text PDF

Immunological studies of Burkholderia multivorans O-antigen oligosaccharide-rsScpA193 conjugates as potential candidates for vaccine development.

Int J Biol Macromol

December 2024

National Glycoengineering Research Center and NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-based Medicine, Shandong University, 72 Binhai Road, Qingdao 266237, China. Electronic address:

The Burkholderia cepacia complex (Bcc) is a group of phenotypically similar but genotypically diverse Gram-negative bacteria that pose a significant threat to public health worldwide. Due to the absence of effective therapies, the development of an effective vaccine against Bcc infection is urgently needed. Lipopolysaccharide (LPS) O-antigens of B.

View Article and Find Full Text PDF
Article Synopsis
  • - Fluorescently labeled (strept)avidins are commonly used to detect biotinylated molecules in immunology and histochemistry, but they can also bind to various glycans, including components of blood group antigens and other oligosaccharides.
  • - This binding occurs in a dose-dependent manner, meaning that the presence of certain polymeric glycan conjugates can inhibit this interaction, but monomeric forms do not have the same effect.
  • - The ability of (strept)avidins to bind glycans may lead to inaccuracies in carbohydrate sample analysis, suggesting that researchers should avoid using excessive amounts of (strept)avidin in their experiments to minimize these errors.
View Article and Find Full Text PDF

Chitooligosaccharide-modified PLGA-loaded PPD nanoparticles ameliorated sepsis-associated acute kidney injury the NF-κB signaling pathway.

Drug Dev Ind Pharm

December 2024

Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), School of Pharmacy, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, P. R. China.

Objectives: Sepsis-associated acute kidney injury (SA-AKI) is a significant clinical challenge with high morbidity and mortality. Low bioavailability of protopanaxadiol (PPD) limits its clinical application. In this study, PPD was encapsulated with chitooligosaccharide (COS) modified polylactic-co-glycolic acid (PLGA) to develop novel nanomedicines for the treatment of SA-AKI.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!